Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ezekowitz

Showing results (511-520 of 1,022) with videos related to

Pageof 103
Sort By:
Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology|April 26, 2008
Beneficial effects of fenofibrate on plaque thrombogenicity and plaque stability in atherosclerotic rabbitsEmmanuelle Jeanpierre, Thierry Le Tourneau, Christophe Zawadzki, et al.
Heart (British Cardiac Society)|February 19, 2017
Effects of dabigatran according to age in atrial fibrillationMandy N Lauw, John W Eikelboom, Michiel Coppens, et al.
Journal of Cardiac Failure|November 9, 2010
Comparison of direct body composition assessment methods in patients with chronic heart failureAntigone Oreopoulos, Kamyar Kalantar-Zadeh, Finlay A McAlister, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 23, 2006
The differing roles of the classical and mannose-binding lectin complement pathways in the events following skeletal muscle ischemia-reperfusionRodney K Chan, Shahrul I Ibrahim, Kazue Takahashi, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|October 22, 2015
Patient-reported treatment satisfaction and budget impact with rivaroxaban vs. standard therapy in elective cardioversion of atrial fibrillation: a post hoc analysis of the X-VeRT trialStefan H Hohnloser, Riccardo Cappato, Michael D Ezekowitz, et al.
Circulation|April 13, 2016
Electrocardiographic Early Repolarization: A Scientific Statement From the American Heart AssociationKristen K Patton, Patrick T Ellinor, Michael Ezekowitz, et al.
The American Journal of Medicine|June 6, 2016
Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants After Cardioversion for Nonvalvular Atrial FibrillationGiulia Renda, Marco Zimarino, Fabrizio Ricci, et al.
American Heart Journal|September 7, 2016
Apixaban compared with parenteral heparin and/or vitamin K antagonist in patients with nonvalvular atrial fibrillation undergoing cardioversion: Rationale and design of the EMANATE trialMichael D Ezekowitz, Charles V Pollack, Paul Sanders, et al.
JACC. Heart Failure|April 29, 2017
Impact of Current Versus Previous Cardiac Resynchronization Therapy Guidelines on the Proportion of Patients With Heart Failure Eligible for TherapyKristin J Lyons, Justin A Ezekowitz, Li Liang, et al.
Journal of Cardiac Failure|March 9, 2016
Dichotomous Relationship Between Age and 30-Day Death or Rehospitalization in Heart Failure Patients Admitted With Acute Decompensated Heart Failure: Results From the ASCEND-HF TrialDavid J Whellan, Amanda Stebbins, Adrian F Hernandez, et al.
Pageof 103

Showing results (511-520 of 1,022) with videos related to

Sort By:
Pageof 103
Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology|April 26, 2008
Beneficial effects of fenofibrate on plaque thrombogenicity and plaque stability in atherosclerotic rabbitsEmmanuelle Jeanpierre, Thierry Le Tourneau, Christophe Zawadzki, et al.
Heart (British Cardiac Society)|February 19, 2017
Effects of dabigatran according to age in atrial fibrillationMandy N Lauw, John W Eikelboom, Michiel Coppens, et al.
Journal of Cardiac Failure|November 9, 2010
Comparison of direct body composition assessment methods in patients with chronic heart failureAntigone Oreopoulos, Kamyar Kalantar-Zadeh, Finlay A McAlister, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 23, 2006
The differing roles of the classical and mannose-binding lectin complement pathways in the events following skeletal muscle ischemia-reperfusionRodney K Chan, Shahrul I Ibrahim, Kazue Takahashi, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|October 22, 2015
Patient-reported treatment satisfaction and budget impact with rivaroxaban vs. standard therapy in elective cardioversion of atrial fibrillation: a post hoc analysis of the X-VeRT trialStefan H Hohnloser, Riccardo Cappato, Michael D Ezekowitz, et al.
Circulation|April 13, 2016
Electrocardiographic Early Repolarization: A Scientific Statement From the American Heart AssociationKristen K Patton, Patrick T Ellinor, Michael Ezekowitz, et al.
The American Journal of Medicine|June 6, 2016
Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants After Cardioversion for Nonvalvular Atrial FibrillationGiulia Renda, Marco Zimarino, Fabrizio Ricci, et al.
American Heart Journal|September 7, 2016
Apixaban compared with parenteral heparin and/or vitamin K antagonist in patients with nonvalvular atrial fibrillation undergoing cardioversion: Rationale and design of the EMANATE trialMichael D Ezekowitz, Charles V Pollack, Paul Sanders, et al.
JACC. Heart Failure|April 29, 2017
Impact of Current Versus Previous Cardiac Resynchronization Therapy Guidelines on the Proportion of Patients With Heart Failure Eligible for TherapyKristin J Lyons, Justin A Ezekowitz, Li Liang, et al.
Journal of Cardiac Failure|March 9, 2016
Dichotomous Relationship Between Age and 30-Day Death or Rehospitalization in Heart Failure Patients Admitted With Acute Decompensated Heart Failure: Results From the ASCEND-HF TrialDavid J Whellan, Amanda Stebbins, Adrian F Hernandez, et al.
Pageof 103